Minerva surgical announces appointment of derrick sung, ph.d. to board of directors

Santa clara, calif., july 21, 2022 (globe newswire) -- minerva surgical, inc. (nasdaq: utrs) (“minerva surgical” or the “company”), a woman's health company focused on the treatment of abnormal uterine bleeding (aub), today announced that the board of directors (the “board”) of minerva surgical has appointed derrick sung, ph.d. to serve as a class ii director, with a term expiring at the 2023 annual meeting of stockholders or until his successor has been duly elected and qualified. the board has affirmatively determined that dr. sung is an independent director pursuant to the listing standards of the nasdaq stock market.
UTRS Ratings Summary
UTRS Quant Ranking